Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma

Serum hepatitis B core-related antigen (HBcrAg) was shown to predict the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients undergoing treatment. We investigated the longitudinal profile of HBcrAg in entecavir (ETV)-treated CHB patients with subsequent HCC development. We i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Liver
Hlavní autoři: Mak, Lung-Yi, Ko, Kwan-Lung, To, Wai-Pan, Wong, Danny Ka-Ho, Seto, Wai-Kay, Fung, James, Yuen, Man-Fung
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial Office of Gut and Liver 2020
Témata:
Brief Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7492492/
https://ncbi.nlm.nih.gov/pubmed/32457279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19434
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky